Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus

Abstract

Background A 38-year-old woman with systemic lupus erythematosus presented with headaches and bilateral hearing loss. Brain MRI was initially suggestive of small-vessel disease developing in the context of neuropsychiatric systemic lupus erythematosus. Several months later, the patient developed optic neuritis, followed by recurrent attacks of myelitis.

Investigations MRI of the spine revealed multifocal regions of myelitis affecting the cervical spine. Serological evaluation revealed the presence of neuromyelitis optica-IgG antibodies. MRI of the brain was nondiagnostic for multiple sclerosis.

Diagnosis Recurrent myelitis and optic neuritis, occurring in the context of neuromyelitis optica (also known as Devic's syndrome).

Management The patient had recurrent attacks of myelitis despite treatment with pulse cyclophosphamide. After initiation of rituximab, the patient experienced symptomatic improvement and had no further attacks of opticospinal disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Axial MRI of the brain performed upon onset of headaches and sensorineural hearing loss.
Figure 2: Sagittal T2-weighted MRI of spine, performed 19 months after initial hearing loss and headache, shows multifocal, hyperintense lesions at C5–C6 and C7–T1 (arrows).
Figure 3: Axial T2-weighted MRI of brain, performed in the month before referral, shows bilateral, hyperintense, white-matter lesions in corona radiata.

References

  1. Dyck PJ et al. (2005) History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation. J Peripher Nerv Syst 10: 158–173

    Article  Google Scholar 

  2. Frohman EM (2003) Multiple sclerosis. Med Clin North Am 87: 867–897

    Article  Google Scholar 

  3. Balcer LJ (2006) Clinical practice. Optic neuritis. N Engl J Med 354: 1273–1280

    Article  CAS  Google Scholar 

  4. Beck RW et al. (2003) High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 121: 944–999

    Article  Google Scholar 

  5. Charil A et al. (2006) MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol 5: 841–852

    Article  Google Scholar 

  6. Barkhof F et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120: 2059–2069

    Article  Google Scholar 

  7. Link H and Huang YM (2006) Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 180: 17–28

    Article  CAS  Google Scholar 

  8. Salvarani C et al. (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62: 442–451

    Article  Google Scholar 

  9. Johnson RT and Richardson EP (1968) The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 47: 337–369

    Article  CAS  Google Scholar 

  10. Birnbaum J and Kerr D (2007) Devic's syndrome in a woman with systemic lupus erythematosus: diagnostic and therapeutic implications of testing for the neuromyelitis optica IgG autoantibody. Arthritis Rheum 57: 347–351

    Article  Google Scholar 

  11. Mathews MK (2005) Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol 16: 341–345

    Article  Google Scholar 

  12. Wingerchuk DM et al. (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485–1489

    Article  CAS  Google Scholar 

  13. Wingerchuk DM et al. (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107–1114

    Article  CAS  Google Scholar 

  14. Lennon VA et al. (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473–477

    Article  CAS  Google Scholar 

  15. Pittock SJ et al. (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65: 78–83

    PubMed  Google Scholar 

  16. Ferreira S et al. (2005) Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand. Rheumatology (Oxford) 44: 434–442

    Article  CAS  Google Scholar 

  17. Wingerchuk DM et al. (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6: 805–815

    Article  CAS  Google Scholar 

  18. Wingerchuk DM and Weinshenker BG (2005) Neuromyelitis optica. Curr Treat Options Neurol 7: 173–182

    Article  Google Scholar 

  19. Lucchinetti CF et al. (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125: 1450–1461

    Article  Google Scholar 

  20. Cree BA et al. (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64: 1270–1272

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Désirée Lie, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscapeaccredited continuing medical education activity associated with this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julius Birnbaum.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Birnbaum, J., Kerr, D. Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus. Nat Rev Rheumatol 4, 381–386 (2008). https://doi.org/10.1038/ncprheum0818

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0818

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing